Sen. Ted Cruz (R-Texas) on Tuesday made a personal plea for the federal government to spend more to cure diseases like Alzheimer’s, which took the life of his grandmother.
In a subcommittee hearing he convened, Cruz struck a dramatic tone as he lambasted the government’s current spending levels for diseases like Alzheimer’s and cancer.
“We’re spending over $1.1 trillion a year in treatment costs, and we’re investing collectively about $9.9 billion in medical research,” he told a panel, which included former Sen. Tom Coburn (R-Okla.), who left office last year to fight prostate cancer.
{mosads}“Does that ratio seem appropriate, not only in terms of dollars and cents, but also in terms of the human lives that are dealing with the terrible consequences?” he asked the subcommittee’s panel.
Blasting the “regulatory burdens of uncertainty,” Cruz joined several of his Republican colleagues in urging reforms of the Food and Drug Administration.
Coburn, who was trained as a medical doctor, pointed to the recently passed House bill, the 21st Century Cures Act, which includes an overhaul of the FDA.
The former senator called the bill a “good start,” highlighting its bipartisan backing, but he said the Senate’s companion bill should focus far more on payment and intellectual property reforms.
“If we really want to get new advances and if we really want to hurry it up … then what we have to do is change intellectual property and change the way we pay for it,” Coburn said.
The hearing also turned personal for Sen. Ron Johnson (R-Wis.), who spoke about his daughter, who was born with a serious congenital heart defect.
But members overall spoke little of the House’s cures bill, which also includes a nearly $9 billion increase in funding for the National Institutes of Health.
That bill has drawn concern from Cruz’s conservative counterparts in the House, who argue that any funding increase should be discretionary — requiring Congress to revisit it each year — instead of mandatory
The bill also includes additional funding for the FDA, an agency that Coburn acknowledged is deeply strained financially.
“I think we’re way underfunded, but I think we need to have better oversight because they make some errors that are just plain stupid,” he said.